Clinical application of myelobromol in chronic myeloses. 1966

V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
November 1961, Ceskoslovenska pediatrie,
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
July 1967, Klinicheskaia meditsina,
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
April 1967, Orvosi hetilap,
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
January 1966, Therapia Hungarica (English edition),
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
July 1957, Deutsche medizinische Wochenschrift (1946),
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
January 1963, Neoplasma,
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
May 1957, Medicina interna,
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
January 1969, Therapia Hungarica (English edition),
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
July 1971, Wiadomosci lekarskie (Warsaw, Poland : 1960),
V Cerný, and V Ujházy, and L Sándor, and A Winkler, and M Uhrínová, and C Petrek, and J Halko
February 1968, Klinische Wochenschrift,
Copied contents to your clipboard!